Ability to Maintain or Achieve Clinical and Endoscopic Remission With MMX Mesalamine Once Daily in Adults With Ulcerative Colitis
NCT01124149
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
759
Enrollment
INDUSTRY
Sponsor class
Conditions
Ulcerative Colitis
Interventions
DRUG:
MMX mesalamine/ mesalazine
Sponsor
Shire